tenofovir DF 300 mg qd

DRUG2 trials

Sponsors

Boehringer Ingelheim, RFS Pharma, LLC

Conditions

HIV InfectionsHuman Immunodeficiency Virus Infection

Phase 2

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

TerminatedNCT01737359

RFS Pharma, LLCHuman Immunodeficiency Virus Infection

Start: 2012-12-31End: 2013-03-31Updated: 2014-11-05

Phase 4

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

CompletedNCT00552240

Boehringer IngelheimHIV Infections

Start: 2007-09-30Updated: 2014-01-27